Genmab — November 2014
-
Vi når 300 inden 31/12

-
flot luk på en rød dag
-
Har desværre en aftale der. Men skal da helt sikkert lytte til replay i aften

-
Man kan se slides nu: http://wsw.com/webcast/jeff86/gen/
-
Ofatumumab hedder nu bare cancer autoimmun potential. Ordet blockbuster er væk. Det står der kun udenfor daratumumab
-
jan siger de forventer at lave opt-in snart
-
Tror det er humax-TAC de går efter
-
flere darastudier planlægger mens hans snakker
-
lyder til smoldering snart kommer igang også. Det har analytikerne ikek indregnet i deres modeller
-
non-mm studier med dara starter næste år
-
alle i 16 mg. mono der havde PR eller better og som fik bone marrow kotrol var fuldstændig kræffrie
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind